Report Categories
View AllRecent Articles
View All
PVLA Palvella Therapeutics misses earnings estimates by 26 as stock drops nearly 13 amid pipeline concerns
ARCB ArcBest beats Q1 2026 EPS forecasts by 154 percent sending shares up 175 percent in todays session
What LEIFRAS LFS management said that matters most LFS Q3 Earnings Financial Metrics Remain Unavailable
J Jacobs Solutions reports slight Q1 2026 EPS miss shares climb 306 percent on positive investor sentiment